SAN DIEGO—Cytiva has launched its Sefia next-generation manufacturing platform, with the goal of helping drug developers and larger healthcare providers accelerate their production of chimeric antigen ...
In Muskegon, MI, Cytiva is constructing a second resins manufacturing facility at a site that now employs approximately 100 full-time associates. That number is expected to double by the time the ...
Cambridge, UK and Marlborough, MA, 28 May 2025: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ System, has announced a ...